Evidence map›Paper›PMID 38339132›Full record

ArticleInternational journal of molecular sciences2024

Identification of miR-30c-5p microRNA in Serum as a Candidate Biomarker to Diagnose Endometriosis.

Lucía Chico-Sordo, Tamara Ruiz-Martínez, Mónica Toribio, Roberto González-Martín, Emanuela Spagnolo, Francisco Domínguez, Alicia Hernández, Juan A García-Velasco

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. miRNA in Endometriosis-A New Hope or an Illusion?Journal of clinical medicine · 2025
    Review
  12. MicroRNAs as Biomarkers and Therapeutic Targets in Female Infertility.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lucía Chico-SordoIVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe (IIS La Fe), 46026 Valencia, Spain.
Tamara Ruiz-MartínezGynaecology Department, La Paz University Hospital, 28046 Madrid, Spain.
Mónica ToribioIVIRMA Global Research Alliance, IVIRMA Madrid, 28023 Madrid, Spain.
Roberto González-MartínIVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe (IIS La Fe), 46026 Valencia, Spain.
Emanuela SpagnoloGynaecology Department, La Paz University Hospital, 28046 Madrid, Spain.ORCID 0000-0001-5566-8479
Francisco DomínguezIVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe (IIS La Fe), 46026 Valencia, Spain.ORCID 0000-0002-7620-8081
Alicia HernándezGynaecology Department, La Paz University Hospital, 28046 Madrid, Spain.
Juan A García-VelascoIVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe (IIS La Fe), 46026 Valencia, Spain.ORCID 0000-0003-1005-8727

Funding

the Instituto de Salud Carlos III (ISCIII) PI20/01368the Instituto de Salud Carlos III (Spanish Government) and European Union (ESF, 'Investing in your Future'). R.G-M. CIAPOT/2022/15the Next Generation EU Fund, and Merck KGaA. L.C-S. PFIS FI19/00008
6 · The paper itself

Abstract

The diagnosis of endometriosis by laparoscopy is delayed until advanced stages. In recent years, microRNAs have emerged as novel biomarkers for different diseases. These molecules are small non-coding RNA sequences involved in the regulation of gene expression and can be detected in peripheral blood. Our aim was to identify candidate serum microRNAs associated with endometriosis and their role as minimally invasive biomarkers. Serum samples were obtained from 159 women, of whom 77 were diagnosed with endometriosis by laparoscopy and 82 were healthy women. First, a preliminary study identified 29 differentially expressed microRNAs between the two study groups. Next, nine of the differentially expressed microRNAs in the preliminary analysis were evaluated in a new cohort of 67 women with endometriosis and 72 healthy women. Upon validation by quantitative real-time PCR technique, the circulating level of miR-30c-5p was significantly higher in the endometriosis group compared with the healthy women group. The area under the curve value of miR-30c-5p was 0.8437, demonstrating its diagnostic potential even when serum samples registered an acceptable limit of hemolysis. Dysregulation of this microRNA was associated with molecular pathways related to cancer and neuronal processes. We concluded that miR-30c-5p is a potential minimally invasive biomarker of endometriosis, with higher expression in the group of women with endometriosis diagnosed by laparoscopy.

Indexed as

EndometriosisMicroRNAsBiomarkersCell DeathFemaleHumansReal-Time Polymerase Chain ReactionBiomarkersMicroRNAsbiomarkerdiagnosisendometriosismicroRNAsmiR-30c-5pserum

Identifiers

PMID38339132
PMCPMC10855247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.